Synopsis
Synopsis
0
USDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ba 21401
2. Ba-21401
3. Ciba 21401 Ba
4. Ciba 21401-ba
5. Ethyl 3,5,6-tri-o-benzyl-d-glucofuranoside
6. Glyvenol
7. Tribenol
8. Tribenoside, (alpha)-isomer
9. Tribenoside, (beta)-isomer
1. 10310-32-4
2. Ethyl 3,5,6-tri-o-benzyl-d-glucofuranoside
3. (3r,4r,5r)-4-(benzyloxy)-5-((r)-1,2-bis(benzyloxy)ethyl)-2-ethoxytetrahydrofuran-3-ol
4. D-glucofuranoside, Ethyl 3,5,6-tris-o-(phenylmethyl)-
5. Tbgf
6. Hemocuron
7. Glyvenol
8. 21401-ba
9. Z7n0y673nu
10. Tribenzoside
11. Glyvenal
12. Tribenosido
13. Tribenosidum
14. Glivenol
15. Dsstox_cid_3697
16. Tribenosidum [inn-latin]
17. Tribenosido [inn-spanish]
18. Unii-z7n0y673nu
19. Tribenoside [usan:inn:ban:jan]
20. Einecs 233-687-2
21. Ba 21401
22. Bg-356
23. Tribenoside [mi]
24. Prestwick3_001019
25. Tribenoside [inn]
26. Tribenoside [jan]
27. Ethyl-3,5,6-tri-o-benzyl-d-glucofuranoside
28. Tribenoside [usan]
29. Tribenoside [mart.]
30. Bspbio_001177
31. Tribenoside [who-dd]
32. Bpbio1_001295
33. Schembl7192326
34. Chembl3301681
35. D-glucofuranoside, Ethyl-3,5,6-tris-o-(phenylmethyl)-
36. Chebi:91780
37. Hms2098k19
38. Hms3715k19
39. Tribenoside [ep Monograph]
40. Ba 2140
41. Ex-a4214
42. Mfcd00801089
43. Akos022185031
44. Ccg-221019
45. Db13227
46. (3r,4r,5r)-5-[(1r)-1,2-bis(phenylmethoxy)ethyl]-2-ethoxy-4-phenylmethoxyoxolan-3-ol
47. Ncgc00179274-01
48. Bs-25775
49. Hy-108249
50. Ab00514005
51. Cs-0027714
52. F20469
53. 310t324
54. A896620
55. Glucofuranoside, Ethyl-3,5,6-tri-o-benzyl-, D-
56. Q533119
57. Sr-01000872695
58. Sr-01000872695-1
59. W-200685
60. Brd-a60294240-001-01-1
61. (3r,4r,5r)-5-[(1r)-1,2-bis(phenylmethoxy)ethyl]-2-ethoxy-4-phenylmethoxy-3-oxolanol
Molecular Weight | 478.6 g/mol |
---|---|
Molecular Formula | C29H34O6 |
XLogP3 | 3.9 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 13 |
Exact Mass | 478.23553880 g/mol |
Monoisotopic Mass | 478.23553880 g/mol |
Topological Polar Surface Area | 66.4 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 555 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
C - Cardiovascular system
C05 - Vasoprotectives
C05A - Agents for treatment of hemorrhoids and anal fissures for topical use
C05AX - Other agents for treatment of hemorrhoids and anal fissures for topical use
C05AX05 - Tribenoside
C - Cardiovascular system
C05 - Vasoprotectives
C05C - Capillary stabilizing agents
C05CX - Other capillary stabilizing agents
C05CX01 - Tribenoside
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?